4//SEC Filing
Beetham Thomas W. 4
Accession 0000950170-23-057520
CIK 0001590750other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:35 PM ET
Size
5.6 KB
Accession
0000950170-23-057520
Insider Transaction Report
Form 4
Beetham Thomas W.
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-30+474,400→ 474,400 totalExercise: $13.02Exp: 2023-10-30→ Common Stock (474,400 underlying)
Footnotes (1)
- [F1]The option vests as to 25% on October 30, 2024 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001741382
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:35 PM ET
- Size
- 5.6 KB